Soler N G, Exon P D, Paton A
Br Med J. 1974 Nov 23;4(5942):447-9. doi: 10.1136/bmj.4.5942.447.
Twenty-three patients with obstructive jaundice were given a 50-g oral glucose tolerance test (G.T.T.) and an insulin stimulation test with oral glucose and intravenous tolbutamide and glucagon. An abnormal glucose response was as common in patients with carcinoma of the pancreas (seven out of 12) as in patients with "other" causes of obstructive jaundice (six out of 11). Though both groups had a low and delayed insulin response the insulin levels were significantly lower in patients with carcinoma of the pancreas. After the insulin stimulation test patients with obstructive jaundice who did not have carcinoma of the pancreas had a greater and significantly different insulin response from patients with pancreatic cancer. There was, however, considerable overlapping between the results of individual patients in the two groups.
对23例梗阻性黄疸患者进行了50克口服葡萄糖耐量试验(G.T.T.),以及口服葡萄糖、静脉注射甲苯磺丁脲和胰高血糖素的胰岛素刺激试验。胰腺肿瘤患者(12例中有7例)出现异常葡萄糖反应的情况与梗阻性黄疸“其他”病因患者(11例中有6例)一样常见。虽然两组患者的胰岛素反应均较低且延迟,但胰腺肿瘤患者的胰岛素水平显著更低。胰岛素刺激试验后,无胰腺肿瘤的梗阻性黄疸患者的胰岛素反应比胰腺癌患者更强且差异显著。然而,两组个体患者的结果存在相当大的重叠。